⌘K

Home/Filings/4/0001048477-24-000128

4//SEC Filing

Burkhart Erin 4

Accession 0001048477-24-000128

CIK 0001048477other

View on SEC.gov Company Profile

Filed

Aug 14, 8:00 PM ET

Accepted

Aug 15, 3:57 PM ET

Size

4.6 KB

Accession

0001048477-24-000128

Insider Transaction Report

Form 4

Period: 2024-08-13

BIOMARIN PHARMACEUTICAL INCBMRN

GVP, Chief Accounting Officer

Transactions

Sale
Common Stock
2024-08-13$90.00/sh−714$64,260→ 14,449 total

Footnotes (1)

[F1]Trade made pursuant to a 10b5-1 plan executed on November 29, 2023.

Documents

1 file

4
wk-form4_1723751821.xmlPrimary
FORM 4

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1

filerCIK 0001927648

Filing Metadata

Form type: 4
Filed: Aug 14, 8:00 PM ET
Accepted: Aug 15, 3:57 PM ET
Size: 4.6 KB

View on SEC.gov